Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letters to the Editor
  • Published:

C75 inhibits food intake by increasing CNS glucose metabolism

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Models in which CNS reliance on glucose metabolism is reduced, and effects of C75 are attenuated.

References

  1. Shimokawa, T., Kumar, M.V. & Lane, M.D. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides. Proc. Natl. Acad. Sci. USA 99, 66–71 (2002).

    Article  CAS  Google Scholar 

  2. Makimura, H. et al. Cerulenin mimics effects of leptin on metabolic rate, food intake, and body weight independent of the melanocortin system, but unlike leptin, cerulenin fails to block neuroendocrine effects of fasting. Diabetes 50, 733–739 (2001).

    Article  CAS  Google Scholar 

  3. Loftus, T.M. et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288, 2379–2381 (2000).

    Article  CAS  Google Scholar 

  4. Kumar, M.V., Shimokawa, T., Nagy, T.R. & Lane, M.D. Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice. Proc. Natl. Acad. Sci. USA 99, 1921–1925 (2002).

    Article  CAS  Google Scholar 

  5. Kim, E.-K. et al. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment. Am. J. Physiol. Endocrinol. Metab. 283, E867–E879 (2002).

    Article  CAS  Google Scholar 

  6. Clegg, D.J., Wortman, M.D., Benoit, S., McOsker, C. & Seeley, R.J. Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion. Diabetes 51, 3195–3201 (2002).

    Article  Google Scholar 

  7. Ruderman, N.B., Saha, A.K., Vavvas, D. & Witters, L.A. Malonyl-CoA, fuel sensing, and insulin resistance. Am. J. Physiol. 276, E1–E18 (1999).

    CAS  Google Scholar 

  8. Obici, S. et al. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51, 271–275 (2002).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

These studies were supported by National Institutes of Health grants DK54890 and DK17844 and by Procter & Gamble. This work was approved by the University of Cincinnati Institutional Animal Care and Use Committee.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew D. Wortman.

Ethics declarations

Competing interests

Our lab receives funds from an unrestricted education grant from Proctor & Gamble.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wortman, M., Clegg, D., D'Alessio, D. et al. C75 inhibits food intake by increasing CNS glucose metabolism. Nat Med 9, 483–485 (2003). https://doi.org/10.1038/nm0503-483

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0503-483

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing